Article
Classic and Variants APLs, as Viewed from a Therapy Response
14 Apr 2020
Abstract excerpt
Most acute promyelocytic leukemia (APL) are caused by PML-RARA, a translocation-driven fusion oncoprotein discovered three decades ago. Over the years, several other types of rare X-RARA fusions have been described, while recently, oncogenic fusion proteins involving other retinoic acid receptors (RARB or RARG) have been associated to very rare cases of acute promyelocytic leukemia. PML-RARA driven pathogenesis...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
